ReutersNovartis melanoma drug combination wins EU green lightReutersLONDON European regulators on Friday recommended the use of a combination of Novartis's drugs Tafinlar and Mekinist for treating certain patients with melanoma, boosting prospects for medicines acquired from GlaxoSmithKline. The Swiss drugmaker ...Novartis combination therapy Tafinlar(R) and Mekinist(R) achieves important EU ...MarketWatchNovartis combination therapy Tafinlar® and Mekinist® achieves important EU and ...Nasdaqall 7 news articles »
Novartis melanoma drug combination wins EU green light
Rating: 4.5
Diposkan Oleh: Unknown
